I was losing ₹2,028 every month, and I had no idea until ChatGPT told me
I opened ChatGPT and typed:
'Help me cancel all the useless subscriptions I've been paying for.'
Ten minutes later, I had saved ₹ 2,028. Real money. No hacks. No coupon codes. Just a little clarity, a little help, and a big clean-up.
Let me show you how I did it.
I'd been meaning to cancel stuff for months, but let's be honest, it's tedious. So I turned to ChatGPT and asked:
'Can you help me find and cancel old app and service subscriptions I'm no longer using?'
ChatGPT instantly gave me search phrases to dig through my Gmail and UPI history: 'Your subscription has been renewed'
'Auto-debit confirmation'
'Payment receipt for…'
'Free trial ended'
I searched. I scanned. I cringed.
Here's what I uncovered in my inbox and bank SMS history:
Subscription
Cost
Status Amazon Prime ₹ 299/month Cancelled Headspace ₹ 899/year Cancelled Gaana+ ₹ 99/month Cancelled Google One (2TB) ₹ 130/month Downgraded
Total saved this month: ₹ 2,028
Ongoing monthly savings: ₹ 603 Amazon Prime : I hadn't ordered anything in 3 months. Streaming? I was on Netflix and YouTube anyway. Cancelled.
: I hadn't ordered anything in 3 months. Streaming? I was on Netflix and YouTube anyway. Cancelled. Headspace : Good app. But I meditated for 4 days, then forgot about it. ₹ 899/year gone—until now.
: Good app. But I meditated for 4 days, then forgot about it. 899/year gone—until now. Gaana+ : I use Spotify full-time. I didn't even know Gaana was still billing me.
: I use Spotify full-time. I didn't even know Gaana was still billing me. Google One: I was using 6% of my 2TB plan. I downgraded to the free 15GB.
That's the money I was paying for nothing.
Note: Subscription prices and plans may change over time. Always check the latest pricing before making changes.
Some apps don't make it easy to cancel. They hide the unsubscribe button or ask you to email support.
'Write a cancellation email for Gaana+, Headspace, and Google One.'
It did. Polite, professional, and direct. I copy-pasted. Sent them out. Replies came in hours later confirming cancellations. No googling. No stress. Just action.
ChatGPT also suggested setting a recurring reminder:
"Check your subscriptions on the 1st of every month."
So I did. And I turned it into a 10-minute personal finance habit. Search Gmail: "subscription renewed", "auto-debit", "invoice"
Review UPI app and bank SMSes
Cancel what you haven't used in the last 30 days
Ask ChatGPT to write emails for hard-to-cancel apps
Add a Google Calendar reminder: 'Subscription cleanup – Monthly'
If you've ever subscribed via Android: Open Google Play Store
Tap your profile → Payments & Subscriptions
Check the list. You might find old apps still draining ₹ 49– ₹ 999 per month
Most people forget this exists. It's a goldmine for finding forgotten expenses.
We often ignore small monthly charges because they feel too small to be significant. 'Just ₹ 99.' But that's how we lose ₹ 2,000+ every few months, without noticing. The real problem isn't money, it's attention. We're too busy to sit down and sort through the mess.
ChatGPT solved that. It cut through the friction. It not only cancelled the subscriptions for me, but also gave me the words, structure and momentum to get it done.
No, but it can help you identify active subscriptions, write cancellation emails, and create a checklist to manage them manually.
Search your Gmail using terms like 'auto-debit', 'subscription renewal', and 'thank you for your payment'. Also check Google Play/App Store and UPI apps.
List all subscriptions, check if you've used them in the last 30 days, and cancel anything that fails the test. Repeat monthly.
We obsess over how to earn more money. But sometimes, the smartest move is to stop wasting what we already have. I didn't need a CA. I didn't need an Excel sheet. I just needed a chat window, 10 uninterrupted minutes, and the willingness to clean up. You probably do too.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Always review your subscriptions carefully and consult with a financial professional if needed before making changes.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
3 hours ago
- Mint
Samsung beats Apple with 7.9% shipment growth, capturing nearly 20% market share in global smartphone market Q2 2025
Samsung has emerged as the clear leader in the global smartphone market, with shipments rising 7.9 per cent year-on-year to 58 million units in the second quarter of 2025, capturing nearly 20 per cent of the market share, according to preliminary data from the International Data Corporation (IDC) Worldwide Quarterly Mobile Phone Tracker. Globally, smartphone shipments increased by a modest 1.0 per cent year-on-year to 295.2 million units in the second quarter of 2025. This slight growth comes amid a challenging economic environment marked by tariff volatility, currency fluctuations, rising inflation, and unemployment, which have collectively tempered consumer demand. These factors particularly affected the lower-end smartphone segments, where price sensitivity is highest, resulting in a noticeable slowdown in shipments of low-end Android devices. The Chinese market, which has traditionally been a significant driver of global smartphone sales, showed a weaker performance in this quarter. Despite the success of the 618 e-commerce festival in terms of sell-through, the promotions were primarily used by original equipment manufacturers (OEMs) and channel partners to clear existing inventory rather than stimulate new shipments. Apple, which was the top brand during the promotional period, saw a one per cent decline in shipments in China. However, strong double-digit growth in emerging markets helped the company record a global shipment increase of 1.5 per cent, with 46.4 million units shipped in total, representing a 15.7 per cent market share. Other leading smartphone makers also posted mixed results. Xiaomi shipped 42.5 million units, holding a 14.4 per cent market share, while vivo's shipments rose 4.8 per cent year-on-year to 27.1 million units. Transsion experienced a slight decline of 1.7 per cent, shipping 25.1 million units. The remainder of the market contracted by 3.1 per cent, indicating that smaller vendors and less established brands struggled in the face of broader market pressures. Despite the political challenges, conflicts, and the complexities posed by tariffs, the smartphone market's one per cent growth signals resilience and suggests a cautious return to expansion. The quarter saw a slew of new model launches featuring innovative designs and AI integration, contributing to the market's eighth consecutive quarter of growth, a trend not seen since 2013. These developments underline the industry's focus on incorporating advanced technology to attract consumers even amid uncertain economic conditions.
Mint
6 hours ago
- Mint
From OnePlus to Samsung: 5 Top flagship-level camera phones you can buy in 2025
From OnePlus to Samsung: 5 Top flagship-level camera phones you can buy in 2025 5 Photos . Updated: 11 Aug 2025, 07:16 PM IST Share Via From powerful Sony sensors to high-resolution selfie shooters, these top 5 smartphones under ₹30,000 bring impressive camera setups. Featuring models from Poco, Realme, OnePlus, Vivo, and Samsung, this lineup covers everything from versatile triple-camera systems to flagship-level stabilization. 1/5The Poco X7 Pro 5G features a 6.73-inch 1.5K AMOLED display, Dimensity 8400 Ultra chipset, 6550mAh battery with 90W charging, and a 50MP Sony camera with OIS. Running HyperOS (Android 15), it offers flagship-level performance, robust water/dust resistance, and long-term software support. (POCO India) 2/5The Realme GT 6T sports a 6.78-inch curved AMOLED display, Snapdragon 7+ Gen 3 chip, 5500mAh battery with 120W charging, and a 50MP Sony camera. Running Realme UI 5.0 (Android 14), it offers high brightness, IP65 protection, and long-term update support. (Realme India) 3/5The OnePlus Nord CE 5 offers a 6.77-inch 120Hz AMOLED display, Dimensity 8350 chip, 7100mAh battery with 80W charging, and a 50MP Sony camera setup. Running OxygenOS 15, it supports up to 1TB expandable storage and promises long-term OS and security updates. (OnePlus) 4/5The Vivo V50e features a 6.77-inch quad-curved AMOLED display, Dimensity 7300 chip, 5600mAh battery with 90W charging, and 50MP cameras on both front and rear. Running Funtouch OS 15 (Android 15), it offers IP68/IP69 protection, HDR10+ support, and long-term software updates. (Vivo India)
New Indian Express
6 hours ago
- New Indian Express
The scalpel's new partner: When AI surgeons step into the operating room
Recently, at a laboratory at Johns Hopkins University, a machine rewrote medical history. A pair of robotic arms, guided not by a surgeon's steady hand but its own artificial intelligence, removed a gallbladder entirely on its own. The robot – Hierarchical Surgical Robot Transformer (SRT-H), identified structures, applied clips, made precise incisions, and sutured the wound with precision. Though performed on a pig cadaver, this was hailed as "the first realistic surgery by a machine with almost no human intervention," it shattered assumptions about what machines could understand in the chaotic, fluid world of biological bodies. This breakthrough is the next step in the 'evolution' of the remote-controlled robots like the da Vinci system, where surgeons operate instruments from a console. The SRT-H, though, is a landmark simply because here it is a machine that interprets visual data, decides actions, and self-corrects errors in real-time. Its intelligence comes from a large language model like ChatGPT, its expertise is learned from watching and absorbing 17 hours of surgical footage where human experts performed the same gallbladder removals. It internalised 16,000 individual motions, learning the dance of dissection, clipping, and extraction. When tested, it succeeded flawlessly eight times, adapting to obscured views, synthetic blood, and shifted starting positions. Most remarkably, it detected and fixed its own mistakes, like a gripper slipping off an artery, without human prompting. I scouted around for the best person to talk about this, and all fingers pointed to Dr. Rajiv Santosham, a pioneering minimally invasive and robotic thoracic surgeon at Apollo Hospitals, Chennai. So, I talked to him about the same. "We never imagined we could fly. So robots performing fully independent surgery feels unimaginable right now. But what they can do is already transforming how we operate. Imagine navigating near a critical vessel. I, as a surgeon, operate blind to what lies immediately behind it. But an AI, fed the patient's pre-op CT scan, can visualise that hidden anatomy in real-time. It could warn me, guide me, prevent a tear. That's not replacement; that's revolutionary assistance." The Surgeon's Perspective – Pragmatism Meets Potential: Dr. Santosham's voice carries the weight of experience as a pioneer of uniportal VATS (video-assisted thoracic surgery) in India – a technique requiring a single 4-centimetre incision. Yet, his excitement about autonomous AI is measured, grounded in daily realities, and acknowledges AI's current limitations. "To test its medical judgment," he shares, "I once fed ChatGPT an ECG image. The diagnosis it gave was completely wrong. I asked it to re-check, double-check, triple-check. It still made a mess of it. So yes, there's a vast chasm between pattern recognition and true clinical understanding. It's a tool, a powerful one, but still evolving." His speciality, thoracic surgery, also tempers his enthusiasm for near-term autonomy. "I do robotic surgery. But frankly, for many lung procedures, they can be a bit… fancy. My uniportal technique often requires smaller access points than robotic arms. Why make three or four larger holes when one small one suffices? For straightforward cases, the robot might actually add complexity, not value." However, he lights up when discussing the specific applications of the tech. "There are procedures where robotic precision combined with AI's spatial awareness could be transformative. Like in urology, gynaecological oncology, and deep pelvic cancers. Places human hands and eyes struggle to reach and see clearly." Crucially, he sees robotics as a democratizing force. "The beauty isn't just precision; it's consistency. Outcomes become less dependent on the individual surgeon's experience or fatigue level. A well-trained machine also reduces the learning curve for a surgeon. Suddenly, complex procedures become safer and more accessible to a wider pool of surgeons, especially in settings with limited specialist access." Despite this, his conclusion on the human role is definitive: "Surgeons won't lose their jobs to machines anytime soon. But surgeons who actively learn to harness AI? They will become the leaders, the innovators. They'll have an undeniable edge over those clinging purely to conventional methods. Hence, adaptation isn't optional; it's the future." Beyond the Lab – Cost, Blame, and the Indian Context: The promise of autonomous surgery collides with practical hurdles: affordability, accountability, and adoption. Dr. Santosham, deeply familiar with India's healthcare landscape, offers a unique perspective on the scepticism about such expensive medical tech reaching the masses. "Remember laparoscopy?" Dr. Santosham asks. "They said it would never reach tier 2 and tier 3 cities in India. It did. Then they said robotic surgery was too expensive, destined only for elite metros. It's now percolating across the country. The Da Vinci system is brilliant, but it's not the only player in the market. China is producing high-quality robotic systems at phenomenally lower costs. India absolutely has the capability to innovate and manufacture affordable versions too. So, bridging this divide will happen. It's a matter of when, not if." He envisions a future where indigenous robotics makes precision surgery accessible far beyond the Metros. The Accountability Question: We all know AI is prone to errors, and worse – hallucinations. So, when an autonomous robot errs, whose responsibility would that be? Dr. Santosham addresses this head-on, drawing a sharp distinction from the rapid, crisis-driven deployment of technologies like COVID-19 vaccines. "Medical technology, especially something as critical as autonomous surgery, undergoes incredibly rigorous testing before approval," he states. "Think of the scrutiny applied in the US by the FDA. By the time a system is cleared for human use, the chances of catastrophic error are minimised. And let's be clear: human surgeons make mistakes too. Perfection is a myth, whether flesh or silicon. The key is robust failsafes." He draws parallels to existing safety features in current robotic systems: "If I glance away during a robotic suture, the system detects my diverted attention and freezes all instrument movement instantly. They filter out hand tremors. These are designed to prevent human error. Autonomous systems will build layers upon layers of such safeguards." Regulation and Indian Adoption: While looking towards US and EU regulatory benchmarks, Dr. Santosham is bullish on India's embrace of the technology. "India has a remarkable capacity for technological leapfrogging," he asserts. "We often focus on the challenges of poverty, but underestimate the sheer scale of wealth and technological ambition in our major cities. Chennai, Hyderabad, Bangalore, Mumbai, Delhi—these are hubs with world-class hospitals and patients demanding the latest innovations. They will invest in, adopt, and eventually even build and export advanced autonomous surgical systems. Affordability, driven by local innovation and scale, will follow." The Road Ahead – Collaboration, Not Conquest: The vision emerging from labs like Johns Hopkins and the insights of surgeons like Dr. Santosham point not to a dystopian replacement of humans, but to a powerful, evolving partnership. The SRT-H robot wasn't designed for isolation. During its successful trials, human surgeons remained present, offering verbal guidance: "Move the left arm slightly," or "Switch to the curved scissors." The AI understood and complied. This interaction is the blueprint – autonomy that enhances human oversight, not eliminate it. The immediate future hence lies in collaborative autonomy, where AI handles predictable, precision-critical tasks under a surgeon's supervisory command, freeing the human expert to manage the overall strategy, complex decision-making, and unexpected complications. The statistics supporting this hybrid approach are compelling. Meta-analyses of existing robot-assisted surgery (still human-controlled) already show tangible benefits: operations completed 25% faster, a 30% reduction in complications during surgery, and patients recovering 15% quicker. Autonomous systems, once matured, promise to amplify these gains while tackling the persistent shortage of highly skilled surgeons, particularly in specialised fields and underserved regions. The final goal transcends mere technical achievements. It's about democratisation of medical tech. As Dr. Santosham implies, it's about ensuring that a child in a remote village doesn't face a life-threatening condition simply because an experienced surgeon isn't at hand. It's about making the collective genius of global surgical expertise accessible through intelligent machines, guided by local medical professionals. The autonomous incision at Johns Hopkins wasn't just into tissue; it was the first cut into a future where the best possible surgery isn't a privilege of geography or wealth, but distributed equally for all. The journey will demand rigorous validation, ethical frameworks, cultural acceptance, and continued human ingenuity. But as Dr. Santosham concludes with characteristic pragmatism and foresight: "India embraced robots; it'll embrace autonomy too. We'll afford it, build it, master it. The surgeon's role will evolve, but the need for human judgment, compassion, and responsibility? That remains eternal." The scalpel has a new partner, and together, they are rewriting the rules of healing. One successfully operated body at a time.
